FDA authorizes monoclonal antibody treatment effective against omicron variant 

Feb 11, 2022 - 03:24 PM
FDA-update-generic-drugs

The Food and Drug Administration today authorized emergency use of the monoclonal antibody bebtelovimab to treat COVID-19 in outpatients at risk of progressing to severe disease or hospitalization. The Department of Health and Human Services yesterday announced plans to distribute at least 600,000 free treatment courses of the drug to states. The government has agreed to buy the treatment courses from Eli Lilly for delivery in February and March, with an option to purchase 500,000 additional doses in the future, the agency said.
 
“Early data suggests that this new product by Lilly has activity against both Omicron and the BA.2 Omicron subvariant,” HHS said. “Should the BA.2 subvariant grow in proportion in the U.S., this potential treatment may help ensure that we can continue to offer monoclonal antibody treatment that works against that strain of the virus.”
 
 

Related News Articles

Headline
CDC report finds COVID-19 vaccine for children reduced chances of ED, urgent care visits
The Centers for Disease Control and Prevention Dec. 11 released a report that found last year’s version of the COVID-19 vaccine was 76% effective in preventing…
Headline
AHA responds to FDA request for information on AI-enabled medical devices
The AHA provided recommendations to the Food and Drug Administration Dec. 1 in response to a request for information on the measurement and evaluation of…
Headline
Permanent recall issued for Baxter ventilation system
The Food and Drug Administration has identified a Class I recall of Baxter Life2000 Ventilation Systems due to a cybersecurity issue discovered through…
Headline
CDC data shows rise in flu, COVID-19 cases across states 
Flu cases are growing or likely growing in 39 states, according to the latest Centers for Disease Control and Prevention data from Nov. 11. COVID-19…
Headline
Recall issued for mislabeled potassium chloride
The Food and Drug Administration yesterday published an announcement from Otsuka ICU Medical saying that the company issued a voluntary recall for a mislabeled…
Headline
Study finds flu, COVID-19 infection temporarily raises risk of heart attack, stroke 
A study published Oct. 30 by the American Heart Association found that people have an elevated risk of heart attack and stroke following flu and COVID-19…